Abstract:
Method and article for providing a rapid, broad spectrum bacterial control, and a rapid and persistent antiviral control on an inanimate surface is disclosed. In the method, a compound or composition capable of lowering surface pH to less than about 4 is applied to the surface, and preferably is allowed to remain on the surface, and the nonvolatile components of the composition can form a barrier film or layer on a treated surface.
Abstract:
A method of disrupting the transmission of Community- Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) using an activated antibacterial composition is disclosed. Methods of reducing and preventing infections caused by CA-MRSA also are disclosed.
Abstract:
Method and article for providing a rapid, broad spectrum bacterial control, and a rapid and persistent antiviral control on an inanimate surface is disclosed. In the method, a compound or composition capable of lowering surface pH to less than about 4 is applied to the surface, and preferably is allowed to remain on the surface, and the nonvolatile components of the composition can form a barrier film or layer on a treated surface.
Abstract:
A method of providing a rapid, broad spectrum bacterial control, and a rapid persistent antiviral control on a surface, and particularly a mammalian skin surface, is disclosed. In the method, a compound or composition capable of lowering skin pH to less than about 4 is applied to the skin, and preferably is allowed to remain on the skin.
Abstract:
A method of providing a rapid, broad spectrum bacterial control, and a rapid persistent antiviral control on a surface, and particularly a mammalian skin surface, is disclosed. In the method, a compound or composition capable of lowering skin pH to less than about 4 is applied to the skin, and preferably is allowed to remain on the skin.
Abstract:
A method of disrupting the transmission of Community- Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) using an activated antibacterial composition is disclosed. Methods of reducing and preventing infections caused by CA-MRSA also are disclosed.